Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Liver Diseases

  Free Subscription


04.11.2019

1 AJR Am J Roentgenol
2 Am J Gastroenterol
2 Am J Pathol
1 Biochem Biophys Res Commun
1 BMC Cancer
1 Br J Surg
3 Dig Dis Sci
3 Eur Radiol
5 Gut
3 Hepatology
1 Int J Cancer
1 J Gastroenterol Hepatol
1 J Hepatol
2 J Pediatr
1 Lancet Gastroenterol Hepatol
2 Oncogene
4 PLoS One
1 Transplant Proc


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. RONALD J, Bozdogan E, Zaki IH, Kappus MR, et al
    Relative Sarcopenia With Excess Adiposity Predicts Survival After Transjugular Intrahepatic Portosystemic Shunt Creation.
    AJR Am J Roentgenol. 2019 Oct 31:1-6. doi: 10.2214/AJR.19.21655.
    PubMed     Text format     Abstract available


    Am J Gastroenterol


  2. Correction: 18th International Society for Hepatic Encephalopathy and Nitrogen Metabolism Meeting Abstracts.
    Am J Gastroenterol. 2019 Oct 14. doi: 10.14309/ajg.0000000000000431.
    PubMed     Text format    

  3. HAJ M, Rockey DC
    Ammonia Levels Do Not Guide Clinical Management of Patients With Hepatic Encephalopathy Caused by Cirrhosis.
    Am J Gastroenterol. 2019 Oct 14. doi: 10.14309/ajg.0000000000000343.
    PubMed     Text format     Abstract available


    Am J Pathol

  4. JEWELL ML, Gibson JR, Guy CD, Hyun J, et al
    Single cell RNA sequencing identifies YAP1-dependent hepatic mesothelial progenitors in fibrolamellar carcinoma.
    Am J Pathol. 2019 Oct 24. pii: S0002-9440(19)30770.
    PubMed     Text format     Abstract available

  5. LU JG, Ji P, French SW
    The MHC II-CD4 Immunologic Synapse in Alcoholic Hepatitis and Autoimmune Liver Pathology: The Role of Aberrant MHC II in Hepatocytes.
    Am J Pathol. 2019 Oct 25. pii: S0002-9440(19)30771.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  6. XIE B, He X, Guo G, Zhang X, et al
    High-throughput screening identified mitoxantrone to induce death of hepatocellular carcinoma cells with autophagy involvement.
    Biochem Biophys Res Commun. 2019 Oct 22. pii: S0006-291X(19)32016.
    PubMed     Text format     Abstract available


    BMC Cancer

  7. MJELLE R, Dima SO, Bacalbasa N, Chawla K, et al
    Comprehensive transcriptomic analyses of tissue, serum, and serum exosomes from hepatocellular carcinoma patients.
    BMC Cancer. 2019;19:1007.
    PubMed     Text format     Abstract available


    Br J Surg

  8. AOKI T, Kubota K, Hasegawa K, Kubo S, et al
    Significance of the surgical hepatic resection margin in patients with a single hepatocellular carcinoma.
    Br J Surg. 2019 Oct 25. doi: 10.1002/bjs.11329.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  9. BIAN X, He X, Yang L, Wu W, et al
    Prognosis of Hepatocellular Carcinoma Among Cancer Survivors with Other Types of Primary Tumors.
    Dig Dis Sci. 2019 Oct 30. pii: 10.1007/s10620-019-05917.
    PubMed     Text format     Abstract available

  10. LING C, Khalid S, Martin D, Hanson J, et al
    HCCs and HCAs in Non-cirrhotic Patients: What You See May Not Be Enough.
    Dig Dis Sci. 2019 Oct 30. pii: 10.1007/s10620-019-05920.
    PubMed     Text format    

  11. HO SY, Liu PH, Hsu CY, Hsia CY, et al
    A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria.
    Dig Dis Sci. 2019 Oct 28. pii: 10.1007/s10620-019-05813.
    PubMed     Text format     Abstract available


    Eur Radiol

  12. FRAUM TJ, Cannella R, Ludwig DR, Tsai R, et al
    Assessment of primary liver carcinomas other than hepatocellular carcinoma (HCC) with LI-RADS v2018: comparison of the LI-RADS target population to patients without LI-RADS-defined HCC risk factors.
    Eur Radiol. 2019 Oct 25. pii: 10.1007/s00330-019-06448.
    PubMed     Text format     Abstract available

  13. SEMAAN S, Vietti Violi N, Lewis S, Chatterji M, et al
    Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.
    Eur Radiol. 2019 Oct 31. pii: 10.1007/s00330-019-06458.
    PubMed     Text format     Abstract available

  14. GUO H, Liao M, Jin J, Zeng J, et al
    How intrahepatic cholestasis affects liver stiffness in patients with chronic hepatitis B: a study of 1197 patients with liver biopsy.
    Eur Radiol. 2019 Oct 30. pii: 10.1007/s00330-019-06451.
    PubMed     Text format     Abstract available


    Gut

  15. CHEN Y, Lin XY
    Are the 5-hydroxymethylcytosine-based wd-scores really superior over alpha-fetoprotein for the early diagnosis of hepatocellular carcinoma?
    Gut. 2019 Oct 25. pii: gutjnl-2019-319853. doi: 10.1136/gutjnl-2019-319853.
    PubMed     Text format    

  16. LEE SW, Kwon JH, Lee HL, Yoo SH, et al
    Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naive patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis.
    Gut. 2019 Oct 31. pii: gutjnl-2019-318947. doi: 10.1136/gutjnl-2019-318947.
    PubMed     Text format     Abstract available

  17. KASPER P, Goeser T, Nierhoff D
    Oesophageal and scaly skin lesions associated with chronic cholestatic liver disease.
    Gut. 2019 Mar 16. pii: gutjnl-2019-318502. doi: 10.1136/gutjnl-2019-318502.
    PubMed     Text format    

  18. GJORGJIEVA M, Sobolewski C, Dolicka D, Correia de Sousa M, et al
    miRNAs and NAFLD: from pathophysiology to therapy.
    Gut. 2019;68:2065-2079.
    PubMed     Text format     Abstract available

  19. WONG VW, Irles M, Wong GL, Shili S, et al
    Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease.
    Gut. 2019;68:2057-2064.
    PubMed     Text format     Abstract available


    Hepatology

  20. ASRANI SK
    Accurate assessment of renal function in cirrhosis.
    Hepatology. 2019 Oct 25. doi: 10.1002/hep.31006.
    PubMed     Text format     Abstract available

  21. KANWAL F, Kramer J, Li L, Dai J, et al
    Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Non-alcoholic Fatty Liver Disease.
    Hepatology. 2019 Nov 1. doi: 10.1002/hep.31014.
    PubMed     Text format     Abstract available

  22. AMIR M, Vora RS, Tafesh ZH, Jesudian A, et al
    Hepatology Highlights.
    Hepatology. 2019;70:1497-1499.
    PubMed     Text format    


    Int J Cancer

  23. DEVAUD C, Tilkin-Mariame AF, Vignolle-Vidoni A, Souleres P, et al
    FAK alternative splice mRNA variants expression pattern in colorectal cancer.
    Int J Cancer. 2019 Jan 10. doi: 10.1002/ijc.32120.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  24. WU CK, Yang SC, Liang CM, Li YC, et al
    The role of antibiotics in upper gastrointestinal bleeding among cirrhotic patients without major complications after endoscopic hemostasis.
    J Gastroenterol Hepatol. 2019 Nov 1. doi: 10.1111/jgh.14873.
    PubMed     Text format     Abstract available


    J Hepatol

  25. YAU T, Hsu C, Kim TY, Choo SP, et al
    Corrigendum to "Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis" [J Hepatol 71 (2019) 543-552].
    J Hepatol. 2019 Oct 24. pii: S0168-8278(19)30551.
    PubMed     Text format    


    J Pediatr

  26. KUEMMET TJ, Sokumbi O, Chiu YE
    New-Onset Blistering Eruption in a Young Child.
    J Pediatr. 2019;205:290-290.
    PubMed     Text format    

  27. CHEN HL, Li HY, Wu JF, Wu SH, et al
    Panel-Based Next-Generation Sequencing for the Diagnosis of Cholestatic Genetic Liver Diseases: Clinical Utility and Challenges.
    J Pediatr. 2018 Oct 23. pii: S0022-3476(18)31299.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  28. WARD JW, Wiktor SZ, Cooke GS
    Launch of the Coalition for Global Hepatitis Elimination: a recommendation of the Lancet Gastroenterology & Hepatology Commission.
    Lancet Gastroenterol Hepatol. 2019 Sep 30. pii: S2468-1253(19)30319.
    PubMed     Text format    


    Oncogene

  29. XU G, Feng D, Yao Y, Li P, et al
    Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarization.
    Oncogene. 2019 Oct 28. pii: 10.1038/s41388-019-1072.
    PubMed     Text format     Abstract available

  30. GUAN C, He L, Chang Z, Gu X, et al
    ZNF774 is a potent suppressor of hepatocarcinogenesis through dampening the NOTCH2 signaling.
    Oncogene. 2019 Oct 28. pii: 10.1038/s41388-019-1075.
    PubMed     Text format     Abstract available


    PLoS One

  31. YU MH, Kim YJ, Park HS, Jung SI, et al
    Shrinkage of hepatocellular carcinoma after radiofrequency ablation following transcatheter arterial chemoembolization: Analysis of contributing factors.
    PLoS One. 2019;14:e0210667.
    PubMed     Text format     Abstract available

  32. WANG S, Shen HW, Chai H, Liang Y, et al
    Complex harmonic regularization with differential evolution in a memetic framework for biomarker selection.
    PLoS One. 2019;14:e0210786.
    PubMed     Text format     Abstract available

  33. CHOUNG S, Kim JM, Joung KH, Lee ES, et al
    Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice.
    PLoS One. 2019;14:e0210828.
    PubMed     Text format     Abstract available

  34. APPLEBY RN, Moghul I, Khan S, Yee M, et al
    Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study.
    PLoS One. 2019;14:e0211348.
    PubMed     Text format     Abstract available


    Transplant Proc

  35. MONT ALVERNE PIERRE AM, Veras CM, Esmeraldo TM, Schwermann MP, et al
    Liver Transplantation for Non-hepatocellular Carcinoma Malignancy: A Single-Center Experience.
    Transplant Proc. 2019 Oct 25. pii: S0041-1345(19)30569.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: